STAT3 and cancer: Until now, numerous STAT3 inhibitors have been discovered and characterized, however; none of them has been approved by FDA for clinical use in the treatment of cancer 8,13, suggesting that mere inhibition of STAT3 is not sufficient enough to effectively eradicate cancer cells.